| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/24/2007 | WO2007057763A2 Nitric oxide as an anti-viral agent, vaccine and vaccine adjuvant |
| 05/24/2007 | WO2007057717A2 Pharmaceutical device for the administration of substances to patients |
| 05/24/2007 | WO2007057714A2 Pharmaceutical compositions comprising methotrexate |
| 05/24/2007 | WO2007057598A2 Pharmaceutical or cosmetic composition and a mixed solubilisation method for the production thereof |
| 05/24/2007 | WO2007057556A1 Method for the qualitative and/or quantitative determination of at least one molecule on a solid surface |
| 05/24/2007 | WO2007057422A1 Process for preparing polyhydroxyalkanoates, polymers thus obtained, compositions comprising same and use thereof |
| 05/24/2007 | WO2007057223A1 Organic compounds comprising a glycopyrronium salt |
| 05/24/2007 | WO2007057222A1 Organic compounds comprising a glycopyrrolium salt |
| 05/24/2007 | WO2007056861A1 Sirna silencing of influenza virus gene expression |
| 05/24/2007 | WO2007041206A3 Drug delivery nanocarriers targeted by landscape phage |
| 05/24/2007 | WO2007038524A3 Cocrystallization methods |
| 05/24/2007 | WO2007036671A3 Microparticles with modified release of at least one active principle and oral galenic form comprising same |
| 05/24/2007 | WO2007028154A3 Encapsulated arsenic drugs |
| 05/24/2007 | WO2007022030A3 Methods and compositions for the efficient delivery of therapeutic agents to cells and animals |
| 05/24/2007 | WO2007020671A8 Ophthalmic compositions containing mucoadhesive polysaccharides able to promote corneal re-epithelization |
| 05/24/2007 | WO2007017291A3 Production of an oxaliplatin mixture and a container and a container set for said mixture |
| 05/24/2007 | WO2007016352A3 Oral liquid losartan compositions |
| 05/24/2007 | WO2007013957A3 Osmotically driven dispense pump and related components for use in high pressure applications |
| 05/24/2007 | WO2007002516A3 Improved dosage forms for movement disorder treatment |
| 05/24/2007 | WO2006135933A3 Stable fixed-dose unitary formulations containing tenofovir, a surfactant, efavirenz and emtricitabine |
| 05/24/2007 | WO2006135932A3 Stable fixed-dose formulations containing a combination of antivirals, method for producing thereof using dry granulation |
| 05/24/2007 | WO2006135506A3 Compositions for topical enzymatic debridement |
| 05/24/2007 | WO2006127561A9 Package assembly for multi-modality functional ingredients in chewing gum compositions |
| 05/24/2007 | WO2006127361A3 Lipid construct for delivery of insulin to a mammal |
| 05/24/2007 | WO2006122551A8 An implantable therapy system for treating a living being with an active factor |
| 05/24/2007 | WO2006120705B1 Treatment and control of severe infections including cystic fibrosis |
| 05/24/2007 | WO2006114277A3 Dosage form with improved release of cefuroximaxetil |
| 05/24/2007 | WO2006055632A3 Pharmaceutical manufacturing process for heat sterilized glucocorticoid suspensions |
| 05/24/2007 | WO2005117842A3 Decontaminant edible product, methods of production and uses thereof |
| 05/24/2007 | WO2005104768A3 System and method for automatic generation of a hierarchical tree network and the use of two complementary learning algorithms, optimized for each leaf of the hierarchical tree network |
| 05/24/2007 | WO2005013891A3 Vaccines using pattern recognition receptor-ligand:lipid complexes |
| 05/24/2007 | WO2005011617A3 Transmucosal dosage forms for brain-targeted steroid chemical delivery systems |
| 05/24/2007 | WO2004087071A3 Use of benzyl alcohol, and other phenolic preservatives to reduce pain during intradermal injection |
| 05/24/2007 | WO2004060266A3 Eye-drop vaccine containing copolymer poly-ye for therapeutic immunization |
| 05/24/2007 | US20070118211 Method for preparing drug eluting medical devices and devices obtained therefrom |
| 05/24/2007 | US20070117959 Novel polyesters |
| 05/24/2007 | US20070117788 Combination of a dopamine D2-receptor agonist and tiotropium or a derivative therof for treating obstructive airways and other inflammatory diseases |
| 05/24/2007 | US20070117783 Aqueous suspensions of ciclesonide for nebulisation |
| 05/24/2007 | US20070117781 Pharmaceutical formulation with improved stability |
| 05/24/2007 | US20070117759 Blister pack and solid dosage form therefor |
| 05/24/2007 | US20070116799 Chewable mass for the remineralization of tooth enamel |
| 05/24/2007 | US20070116777 Ophthalmic preparation containing menthyl ester of indomethacin |
| 05/24/2007 | US20070116776 Particulate drug-containing products and method of manufacture |
| 05/24/2007 | US20070116775 Plastic caviar bead for filling of pillow having function of anti-bacteria |
| 05/24/2007 | US20070116774 Methods and compositions for treating proliferative diseases |
| 05/24/2007 | US20070116773 Metal nanostructures and pharmaceutical compositions |
| 05/24/2007 | US20070116772 Treating diabetes by orally administering insulin containing nanoparticles with a chitosan substrate and polyglutamic acid; may also contain a paracellular transport enhancer such as a Ca2+chelator. |
| 05/24/2007 | US20070116771 Nanoparticles for protein drug delivery |
| 05/24/2007 | US20070116770 Tazobactam/piperacillin lyophilizate |
| 05/24/2007 | US20070116769 Continuous encapsulation process |
| 05/24/2007 | US20070116768 Sustained release preparations composed of biocompatible complex microparticles |
| 05/24/2007 | US20070116767 Chitosan-microparticles for ifn gene delivery |
| 05/24/2007 | US20070116766 Gel compositions as muscle tissue simulant and related articles and methods |
| 05/24/2007 | US20070116765 Aqueous dispersion of hydrogel nanoparticles with inverse thermoreversible gelation |
| 05/24/2007 | US20070116764 Method for treatment of solid pharmaceutical preparation prior to printing and solid pharmaceutical preparation subjected to treatment prior to printing |
| 05/24/2007 | US20070116763 Sustained release oral preparations |
| 05/24/2007 | US20070116762 Compositions of stabilized ramipril in combination with another active agent |
| 05/24/2007 | US20070116761 Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof |
| 05/24/2007 | US20070116760 Pharmaceutical compositions comprising meloxicam and methods of their preparation |
| 05/24/2007 | US20070116759 Pharmaceutical compositions of telmisartan |
| 05/24/2007 | US20070116758 Atorvastatin formulation |
| 05/24/2007 | US20070116757 Methylene Blue Derivatives |
| 05/24/2007 | US20070116756 Stable pharmaceutical compositions |
| 05/24/2007 | US20070116755 Dissolution of arterial cholesterol plaques by pharmacological preparation |
| 05/24/2007 | US20070116754 Dissolution of arterial cholesterol plaques by pharmacological preparation |
| 05/24/2007 | US20070116753 Liposomes useful for drug delivery |
| 05/24/2007 | US20070116752 Transdermal Drug Delivery Device Comprising Extensor-Relaxor Means |
| 05/24/2007 | US20070116751 Medical active substance patch with reduced optical conspicuousness on the skin |
| 05/24/2007 | US20070116748 Top-biased beneficial components on substrates |
| 05/24/2007 | US20070116747 Disposable Plastic Glove with Antiseptic Coating |
| 05/24/2007 | US20070116746 Packaging items containing a human pheromone component |
| 05/24/2007 | US20070116745 Spermicidal preparations and uses thereof |
| 05/24/2007 | US20070116743 Dietary supplement enhancing the muscular energy metabolism, comprising an alkanoyl carnitine and ribose |
| 05/24/2007 | US20070116742 Confectionary products containing a human pheromone component |
| 05/24/2007 | US20070116738 Subcutaneous implants having limited initial release of the active principle and subsequent linearly varying extended release thereof |
| 05/24/2007 | US20070116731 Dermatological cream-gels containing avermectin compounds |
| 05/24/2007 | US20070116730 Pharmaceutical compositions |
| 05/24/2007 | US20070116729 Lyophilization process and products obtained thereby |
| 05/24/2007 | US20070116728 Novel galenical system for active transport, method for preparation and use |
| 05/24/2007 | US20070116719 Vaccine delivery |
| 05/24/2007 | US20070116709 Microemulsions with adsorbed macromolecules and microparticles |
| 05/24/2007 | US20070116700 For subcutaneous administration; hypertonic; useful for preventing self-association of reconstituted lyophilized formulations |
| 05/24/2007 | US20070116697 Nanosphere/microsphere delivery system for the treatment of spinal cord injury |
| 05/24/2007 | US20070116667 Colon cleansing compositions and methods |
| 05/24/2007 | US20070116654 Cosmetics |
| 05/24/2007 | US20070116650 Device, method and use for the formation of small particles |
| 05/24/2007 | US20070116649 Antibiotic formulations, unit doses, kits, and methods |
| 05/24/2007 | US20070114306 Microparticles, microparticle production method, and microparticle production apparatus |
| 05/24/2007 | DE20321455U1 Stabilisiertes pharmazeutisches Erzeugnis, das einen amorphen Wirkstoff enthält A stabilized pharmaceutical product which contains an amorphous active ingredient |
| 05/24/2007 | DE202007002355U1 Wickel oder Auflage Winding or support |
| 05/24/2007 | DE102005055275A1 Phosphatfreie pharmazeutische Zusammensetzung sowie deren Verwendung Phosphate-free pharmaceutical composition and use thereof |
| 05/24/2007 | CA2630224A1 Organic compounds comprising a glycopyrrolium salt |
| 05/24/2007 | CA2630193A1 Pharmaceutical composition free from dexpanthenol, calcium ions, and phosphate, and use of calcium chelating agent and ophthalmologically compatible viscosity regulator |
| 05/24/2007 | CA2630154A1 Segmented pharmaceutical dosage forms |
| 05/24/2007 | CA2629954A1 Methods of producing coated products including active agent and products regarding same |
| 05/24/2007 | CA2629785A1 Pharmaceutical or cosmetic composition and a mixed solubilisation method for the production thereof |
| 05/24/2007 | CA2629437A1 Pharmaceutical compositions comprising methotrexate |
| 05/24/2007 | CA2628666A1 Atorvastatin formulation |
| 05/24/2007 | CA2628630A1 Compositions of lipoxygenase inhibitors |
| 05/24/2007 | CA2628172A1 Organic compounds comprising a glycopyrronium salt |